Article
A glycosylation-related signature can predict prognosis and immunotherapy response in patients with acute myeloid leukaemia
2024-06-18
Abstract excerpt
<title>Abstract</title> <p>Background Acute myeloid leukaemia (AML) are a bunch of malignant tumors derived from hematopoietic stem cells, characterized by high morbidity, high relapse rate and high lethality. Recent years have demonstrated the association between aberrant glycosylation and tumors, but how aberrant glycosylation affects the heterogeneity and prognosis of AML patients remains to be explored. Meth...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 193cb568-7cf8-5c62-8d1a-589bf5e560c6
- DOI
- 10.21203/rs.3.rs-4514468/v1
